chrX-48523809-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 4P and 9B. PP3_StrongBP6BS1BS2

The NM_006579.3(EBP):​c.38C>G​(p.Pro13Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000136 in 1,205,503 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 51 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., 5 hem., cov: 21)
Exomes 𝑓: 0.00014 ( 0 hom. 46 hem. )

Consequence

EBP
NM_006579.3 missense

Scores

13
2
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 6.59

Publications

0 publications found
Variant links:
Genes affected
EBP (HGNC:3133): (EBP cholestenol delta-isomerase) The protein encoded by this gene is an integral membrane protein of the endoplasmic reticulum. It is a high affinity binding protein for the antiischemic phenylalkylamine Ca2+ antagonist [3H]emopamil and the photoaffinity label [3H]azidopamil. It is similar to sigma receptors and may be a member of a superfamily of high affinity drug-binding proteins in the endoplasmic reticulum of different tissues. This protein shares structural features with bacterial and eukaryontic drug transporting proteins. It has four putative transmembrane segments and contains two conserved glutamate residues which may be involved in the transport of cationic amphiphilics. Another prominent feature of this protein is its high content of aromatic amino acid residues (>23%) in its transmembrane segments. These aromatic amino acid residues have been suggested to be involved in the drug transport by the P-glycoprotein. Mutations in this gene cause Chondrodysplasia punctata 2 (CDPX2; also known as Conradi-Hunermann syndrome). [provided by RefSeq, Jul 2008]
EBP Gene-Disease associations (from GenCC):
  • chondrodysplasia punctata 2, X-linked dominant
    Inheritance: XL Classification: DEFINITIVE Submitted by: Illumina
  • MEND syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, ClinGen
  • X-linked chondrodysplasia punctata 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.956
BP6
Variant X-48523809-C-G is Benign according to our data. Variant chrX-48523809-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1965021.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000129 (14/108255) while in subpopulation NFE AF = 0.00023 (12/52285). AF 95% confidence interval is 0.000132. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006579.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EBP
NM_006579.3
MANE Select
c.38C>Gp.Pro13Arg
missense
Exon 2 of 5NP_006570.1Q15125

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EBP
ENST00000495186.6
TSL:1 MANE Select
c.38C>Gp.Pro13Arg
missense
Exon 2 of 5ENSP00000417052.1Q15125
ENSG00000286268
ENST00000651615.1
c.38C>Gp.Pro13Arg
missense
Exon 2 of 7ENSP00000498524.1A0A494C0F3
EBP
ENST00000882073.1
c.38C>Gp.Pro13Arg
missense
Exon 3 of 6ENSP00000552132.1

Frequencies

GnomAD3 genomes
AF:
0.000129
AC:
14
AN:
108255
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000339
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000230
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000946
AC:
17
AN:
179625
AF XY:
0.0000777
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000175
Gnomad OTH exome
AF:
0.000673
GnomAD4 exome
AF:
0.000137
AC:
150
AN:
1097248
Hom.:
0
Cov.:
34
AF XY:
0.000127
AC XY:
46
AN XY:
362648
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26386
American (AMR)
AF:
0.00
AC:
0
AN:
35142
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19362
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30167
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53949
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40488
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4128
European-Non Finnish (NFE)
AF:
0.000170
AC:
143
AN:
841573
Other (OTH)
AF:
0.0000651
AC:
3
AN:
46053
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000129
AC:
14
AN:
108255
Hom.:
0
Cov.:
21
AF XY:
0.000163
AC XY:
5
AN XY:
30675
show subpopulations
African (AFR)
AF:
0.0000339
AC:
1
AN:
29537
American (AMR)
AF:
0.00
AC:
0
AN:
10007
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2629
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3447
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2434
European-Finnish (FIN)
AF:
0.000179
AC:
1
AN:
5583
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.000230
AC:
12
AN:
52285
Other (OTH)
AF:
0.00
AC:
0
AN:
1425
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.000106
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000659
AC:
8

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.77
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.89
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.82
T
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Pathogenic
0.98
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
6.6
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-8.4
D
REVEL
Pathogenic
0.95
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.96
MVP
1.0
MPC
1.6
ClinPred
0.64
D
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.95
gMVP
1.0
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150034611; hg19: chrX-48382197; API